| parent | CLIN | LP7787-7 |
| child | Action taken based on risk assessment meeting | LP310078-3 |
| child | Action taken based on watch record | LP310076-7 |
| child | All-cause deaths since start of event | LP420667-0 |
| child | Analysis of pharmaceutical needs in a region | LP269993-4 |
| child | Healthcare personnel with known health status | LP420383-4 |
| child | Cases among healthcare personnel | LP420407-1 |
| child | Increase or decrease in cases among healthcare personnel compared to previous reporting period | LP420668-8 |
| child | Percent increase or decrease in cases among healthcare personnel compared to previous reporting period | LP420404-8 |
| child | Deaths among healthcare personnel | LP420412-1 |
| child | Increase or decrease in deaths among healthcare personnel compared to previous reporting period | LP420406-3 |
| child | Increase or decrease in deaths compared to previous reporting period | LP420669-6 |
| child | Percent increase or decrease in deaths among healthcare personnel compared to previous reporting period | LP420405-5 |
| child | Deaths | LP269980-1 |
| child | Cause of deaths | LP269981-9 |
| child | Date and time of deaths assessment | LP269979-3 |
| child | Deaths/100,000 population | LP420790-0 |
| child | Percent increase or decrease in deaths compared to previous reporting period | LP420403-0 |
| child | Regional hospitals closed due to event or incident | LP269987-6 |
| child | Regional hospitals closed due to event or incident/Regional hospitals.total | LP286969-3 |
| child | People with confirmed negative lab results | LP270002-1 |
| child | People with confirmed positive lab results | LP270001-3 |
| child | Date of most recent lab test for condition of interest | LP421149-8 |
| child | Result of most recent lab test for condition of interest | LP421150-6 |
| child | Country where diagnosed | LP421157-1 |
| child | Province, state, or region where diagnosed | LP421156-3 |
| child | Date and time of infection control isolation | LP421152-2 |
| child | Isolated per Infection Prevention and Control guidelines | LP421155-5 |
| child | Intensive care unit beds | LP420506-0 |
| child | Intensive care unit beds occupied | LP420393-3 |
| child | Inpatient beds | LP420389-1 |
| child | Inpatient beds occupied | LP420391-7 |
| child | Inpatient beds occupied by patients with disease of interest | LP420392-5 |
| child | Inpatient beds occupied by patients with disease of interest/Inpatient beds occupied | LP420809-8 |
| child | Inpatient beds occupied/Inpatient beds | LP420810-6 |
| child | Number of contacts followed for contact tracing | LP421148-0 |
| child | Countermeasure description | LP270140-9 |
| child | Countermeasure implementation progress | LP270139-1 |
| child | Countermeasure name | LP270141-7 |
| child | Public communication target group | LP268307-8 |
| child | Public communication target region | LP268309-4 |
| PartDisplayName | en-US | PUBLICHEALTH |
| DisplayName | en-US | Public health |
LOINC Version: 2.77
FHIR